Y-mabs enters into partnership with Uruguayan firm to launch cancer drugs in South America

Y-mabs Therapeutics has found distribution partners in South America for its two pediatric cancer drugs.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Y-mabs files for EU approval for pediatric cancer drug
For subscribers
FDA requires more data from Y-mabs
For subscribers